Security key
09058V103
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX)
CUSIP: 09058V103
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 249,150,204
- Total 13F shares
- 133,168,915
- Share change
- +10,561,446
- Total reported value
- $634,861,180
- Put/Call ratio
- 33%
- Price per share
- $4.76
- Number of holders
- 160
- Value change
- +$96,615,986
- Number of buys
- 104
- Number of sells
- 56
Report period
Q2 2020
Institutions
160
Top holders
10
BCRX full security history
Newer quarter: Q3 2020
Previous quarter: Q1 2020
BIOCRYST PHARMACEUTICALS INC SEC filings
BIOCRYST PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09058V103
Recent filing periods:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
13,395,617
|
$26,790,000 | — | 31 Mar 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.4%
|
10,946,166
|
$21,892,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
8,772,116
|
$17,544,000 | — | 31 Mar 2020 | |
| Eversept Partners, LP |
13F
|
Company |
3%
|
7,542,372
|
$15,084,744 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3%
|
7,500,000
|
$15,000,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.6%
|
6,452,341
|
$12,905,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.5%
|
6,109,534
|
$12,219,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
5,746,052
|
$11,492,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
2%
|
5,083,238
|
$10,166,000 | — | 31 Mar 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2%
|
4,877,731
|
$9,755,000 | — | 31 Mar 2020 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.9%
|
4,652,926
|
$9,306,000 | — | 31 Mar 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
3,018,132
|
$6,036,000 | — | 31 Mar 2020 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.2%
|
3,005,676
|
$6,011,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
1%
|
2,556,584
|
$5,113,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.93%
|
2,320,459
|
$4,641,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
2,203,678
|
$4,406,000 | — | 31 Mar 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.84%
|
2,090,969
|
$4,182,000 | — | 31 Mar 2020 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.8%
|
2,000,000
|
$4,000,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
1,869,130
|
$3,738,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.71%
|
1,781,249
|
$3,562,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.64%
|
1,599,912
|
$3,200,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.59%
|
1,464,540
|
$2,929,000 | — | 31 Mar 2020 | |
| Woodline Partners LP |
13F
|
Company |
0.5%
|
1,254,527
|
$2,509,000 | — | 31 Mar 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.46%
|
1,148,846
|
$2,298,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.45%
|
1,131,521
|
$2,263,000 | — | 31 Mar 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.4%
|
995,608
|
$1,991,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.35%
|
874,391
|
$1,749,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.34%
|
859,007
|
$1,719,000 | — | 31 Mar 2020 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.33%
|
815,690
|
$1,632,000 | — | 31 Mar 2020 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.31%
|
771,386
|
$1,543,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
691,848
|
$1,383,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.27%
|
661,546
|
$1,324,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
650,638
|
$1,301,000 | — | 31 Mar 2020 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.25%
|
611,934
|
$1,224,000 | — | 31 Mar 2020 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.19%
|
479,051
|
$958,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.16%
|
390,367
|
$781,000 | — | 31 Mar 2020 | |
| Spark Investment Management LLC |
13F
|
Company |
0.15%
|
372,700
|
$745,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.13%
|
331,655
|
$663,000 | — | 31 Mar 2020 | |
| Swiss National Bank |
13F
|
Company |
0.12%
|
298,800
|
$598,000 | — | 31 Mar 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.1%
|
250,000
|
$500,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
241,320
|
$483,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
228,854
|
$458,000 | — | 31 Mar 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.09%
|
228,600
|
$457,000 | — | 31 Mar 2020 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.08%
|
193,165
|
$382,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.08%
|
191,764
|
$383,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
188,708
|
$377,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.06%
|
161,807
|
$323,000 | — | 31 Mar 2020 | |
| Walleye Capital LLC |
13F
|
Company |
0.06%
|
156,507
|
$313,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
156,500
|
$313,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
144,469
|
$288,000 | — | 31 Mar 2020 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) as of Q2 2020
As of 30 Jun 2020,
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,168,915 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), TWO SIGMA INVESTMENTS, LP, and FMR LLC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
127
Q2 2020 holders
160
Holder diff
33
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.